| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.01 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.04 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
| mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.06 |
| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.06 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |